Genius Group Limited
Genius Group Limited (GNS) Financial Performance & Income Statement Overview
Review Genius Group Limited (GNS) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Genius Group Limited (GNS) Income Statement & Financial Overview
Review Genius Group Limited GNS income statement with detailed quarterly and annual figures.
Metric | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
Revenue | $2.44M | $2.44M | $5.63M | $5.63M |
Cost of Revenue | $1.57M | $1.57M | $2.85M | $2.85M |
Gross Profit | $865170.00 | $865170.00 | $2.79M | $2.79M |
Gross Profit Ratio | $0.35 | $0.35 | $0.49 | $0.49 |
R&D Expenses | $0.00 | $0.00 | $236677.00 | $236677.00 |
SG&A Expenses | $5.02M | $5.02M | $7.65M | $7.65M |
Operating Expenses | $5.40M | $5.40M | $16.24M | $214868.00 |
Total Costs & Expenses | $6.98M | $6.98M | $19.09M | $3.06M |
Interest Income | $0.00 | $0.00 | $847576.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $509981.00 | $509981.00 | $655805.00 | $655805.00 |
EBITDA | -$4.001M | -$4.001M | -$5.08M | -$5.08M |
EBITDA Ratio | -$1.64 | -$1.64 | -$0.90 | -$0.90 |
Operating Income | -$4.54M | -$4.54M | -$13.45M | -$5.73M |
Operating Income Ratio | -$1.86 | -$1.86 | -$2.39 | -$1.02 |
Other Income/Expenses (Net) | -$87970.00 | -$87970.00 | $15.61M | $15.61M |
Income Before Tax | -$4.63M | -$4.63M | $2.15M | $2.15M |
Income Before Tax Ratio | -$1.90 | -$1.90 | $0.38 | $0.38 |
Income Tax Expense | $0.00 | $0.00 | $377010.00 | $377010.00 |
Net Income | -$4.63M | -$4.63M | $2.56M | $2.56M |
Net Income Ratio | -$1.90 | -$1.90 | $0.45 | $0.45 |
EPS | -$0.42 | -$0.42 | $0.33 | $0.03 |
Diluted EPS | -$0.42 | -$0.42 | $0.33 | $0.03 |
Weighted Avg Shares Outstanding | $11.009M | $11.009M | $7.73M | $77.34M |
Weighted Avg Shares Outstanding (Diluted) | $11.009M | $11.009M | $7.73M | $77.34M |
The company's financials show resilient growth, with revenue advancing from $5.63M in Q3 2023 to $2.44M in Q2 2024. Gross profit remained healthy with margins at 35% in Q2 2024 compared to 49% in Q3 2023. Operating income hit -$4.54M last quarter, sustaining a consistent -186% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$4.001M. Net income rose to -$4.63M, while earnings per share reached -$0.42. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan